Psomagen, Inc (formerly Macrogen Corp) is a biotechnology company that performs personalized genome services and aims to link genotypic and phenotypic data for healthcare applications. By using AI to analyze genes and genomes, Psomagen hopes to predict disease risk, diagnose, and treat patients. In early 2020, Psomagen acquired a patent portfolio consisting of 246 documents, along with the anonymized microbiome data from 300,00 samples for $7.05 million from US based biotech company, uBiome.
| Loading Documents... |
